rare adult solid cancers

advertisement
Flyer Rare Tumours (30 Aug)_screen 30.08.2016 13:19 Pagina 3
ESO ADVANCED COURSES, SEMINARS AND SYMPOSIA
ESO-ESMO-RCE
CLINICAL UPDATE ON
RARE ADULT
SOLID CANCERS
25-27 November 2016
Milan, Italy
Chairs:
P.G. Casali, IT
R.A. Stahel, CH
Held in collaboration with:
Held under the auspices of
Flyer Rare Tumours (30 Aug)_screen 30.08.2016 13:19 Pagina 4
INTRODUCTION
Rare cancers make up as many as one fifth of all new cancer cases. Amongst
them, pediatric cancers and rare hematologic neoplasms are often covered by
dedicated educational events, while adult solid rare cancers are hardly
grouped together and approached as a collective group of neoplasms.
Indeed, they account for as many as 15% of all new cancer cases, thus being
the main group within rare cancers. This Course is aimed at dealing with them
on an annual basis, to provide the community of clinical oncologists
specialising in these tumors with a regular update of recent advances in this
specific area. The ultimate goal is to strengthen the educational coverage of a
group of cancers which may be neglected in spite of their collective
incidence.
According to the RARECARE project, which provided a definition and a list of
rare cancers, rare adult solid cancers include the following big families of
tumors, each of them being therefore covered by a corresponding
educational session within this Course:
•
•
•
•
•
•
•
•
•
•
Rare skin cancers and non-cutaneous melanoma
Rare thoracic tumors
Rare female genital cancers
Neuroendocrine tumors
Endocrine gland tumors
Sarcomas
Digestive rare cancers
Rare urological and male genital tumors
Central nervous system neoplasms
Head and neck cancers
Any educational effort in the rare cancer area makes little sense if
disconnected from a networking environment. Thus, this Course will be first
offered to clinical oncologists involved into the existing networks covering
rare adult solid cancers, with a special attention to the new European
Reference Networks due to be created within the EU.
From the educational point of view, one cannot expect that even experienced
clinical oncologists are knowledgeable about all these tumors. For this reason,
the European Faculty of this Masterclass is asked to focus on the most recent
advances, always trying to put them into the context of state-of-the-art
treatment of these tumors, with a special view to ESMO Clinical Practice
Guidelines.
Flyer Rare Tumours (30 Aug)_screen 30.08.2016 13:19 Pagina 1
FACULTY (as of September)
S. Bielack, Klinikum Stuttgart Olgahospital, Stuttgart, DE
J.Y. Blay, Centre Léon Bérard, Lyon, FR
P.G. Casali, Fondazione IRCCS Istituto Nazionale Tumori, Milan, IT
F. de Braud, Fondazione IRCCS Istituto Nazionale Tumori, Milan, IT
F. De Lorenzo, European Cancer Patient Coalition, Brussels, BE
A.P. Dei Tos, Azienda ULSS9, Treviso, IT
R. Elisei, Medicina Clinica e Sperimentale, Università di Pisa, IT
N. Fazio, European Institute of Oncology, Milan, IT
S. Ferrari, Istituti Ortopedici Rizzoli, Bologna, IT
M. Garassino, Fondazione IRCCS Istituto Nazionale Tumori, Milan, IT
R. Glynne-Jones, Mount Vernon Hospital, Northwood, Middlesex, UK
V. Gregoire, Universitè Catholique, Louvain, BE
S. Grisanti, A.O. Spedali Civili, Brescia, IT
L. Licitra, Fondazione IRCCS Istituto Nazionale Tumori, Milan, IT
D. Lorusso, Fondazione IRCCS Istituto Nazionale Tumori, Milan, IT
N. Nicolai, Fondazione IRCCS Istituto Nazionale Tumori, Milan, IT
A. Necchi, Fondazione IRCCS Istituto Nazionale Tumori, Milan, IT
K. Õberg, University Hospital, Uppsala, SE
A. Pica, Proton Therapy Center, Villigen, CH
G. Pravettoni, European Institute of Oncology, Milan, IT
I. Ray-Coquard, Centre Léon Bérard, Lyon, FR
S. Rutkowski, University Medical Center Hamburg-Eppendorf, DE
M. Seckl, Hammersmith Campus, London, UK
C. Simon, Université de Lausanne, CHUV Lausanne, CH
R. Soffietti, AOU San Giovanni Battista, Torino, IT
R.A. Stahel, Clinic for Oncology, Zurich, CH
A. Trama, Fondazione IRCCS Istituto Nazionale Tumori, Milan, IT
Flyer Rare Tumours (30 Aug)_screen 30.08.2016 13:19 Pagina 5
PROGRAMME
FRIDAY, 25 NOVEMBER
INTRODUCTION
11:00
Welcome from ESO and ESMO
11:15
11:30
11:45
12:00
12:15
12:30
Introduction
The epidemiology of rare cancers
The pathologic diagnosis in rare cancers
Patient empowerment in rare cancers
The scenario of rare cancers in the EU
Discussion
13:00
Lunch
A. Costa, IT
R.A. Stahel, CH
P.G. Casali, IT
A. Trama, IT
A.P. Dei Tos, IT
G. Pravettoni
F. De Lorenzo, BE
SESSION 1 RARE THORACIC CANCERS
14:00
14:30
15:00
Mesothelioma
Thymic neoplasms
Discussion
15:30
Coffee break
R.A. Stahel, CH
M. Garassino, IT
SESSION 2 NEUROENDOCRINE TUMORS
16:00
16:30
17:00
Thoracic neuroendocrine tumors
Gastroenteropancreatic neuroendocrine tumors
Discussion
N. Fazio, IT
K. Oeberg, SE
SESSION 3 ENDOCRINE GLAND TUMORS
17:30
18:00
18:30
Thyroid cancer
Adrenal cancer
Discussion
R. Elisei, IT
S. Grisanti, IT
SATURDAY, 26 NOVEMBER
SESSION 4 RARE FEMALE GENITAL TUMORS
8:00
8:30
9:00
9:30
10:00
Carcinoma of vagina and vulva
Rare ovarian cancers
Trophoblastic tumors
Discussion
D. Lorusso, IT
I. Ray-Coquard, FR
M. Seckl, UK
Coffee break
SESSION 5 SARCOMAS
10:30
11:00
Adult soft tissue sarcomas
Gastrointestinal stromal tumors (GIST)
P.G. Casali, IT
J.Y. Blay, FR
Flyer Rare Tumours (30 Aug)_screen 30.08.2016 13:19 Pagina 6
11:30
12:00
12:30
Ewing sarcoma
Osteosarcoma and other bone tumors
Discussion
13:00
Lunch
S. Ferrari, IT
S. Bielack, DE
SESSION 6 RARE UROLOGICAL AND MALE GENITAL
TUMORS
14:00
14:30
15:00
Testicular cancer
Rare urinary cancers
Discussion
15:30
Coffee break
N. Nicolai, IT
A. Necchi, IT
SESSION 7 CENTRAL NERVOUS SYSTEM TUMORS
16:00
16:30
17:00
Glioma
Medulloblastoma
Discussion
R. Soffietti, IT
S. Rutkowski, DE
SESSION 8 RARE SKIN AND NON-CUTANEOUS MELANOMA
17:30
18:00
18:30
Skin adnexal tumors
Uveal and mucosal melanoma
Discussion
L. Licitra, IT
A. Pica, CH
SUNDAY, 27 NOVEMBER
SESSION 9 HEAD AND NECK CANCERS
8:30
9:00
9:30
10:00
10:30
11:00
Laryngeal and hypopharyngeal cancer
Oropharyngeal cancer
Nasopharyngeal cancer
Oral cavity cancer
Salivary glands cancers
Discussion
11:30
Coffee break
C. Simon, CH
V. Gregoire, BE
L. Licitra, IT
C. Simon, CH
L. Licitra, IT
SESSION 10 DIGESTIVE RARE CANCERS
12:00
12:30
13:00
Biliary tumors
Anal carcinoma
Discussion
F. de Braud, IT
R. Glynne-Jones, UK
CLOSING REMARKS
13:30
Take home messages
R.A. Stahel, CH
Flyer Rare Tumours (30 Aug)_screen 30.08.2016 13:19 Pagina 7
GENERAL INFORMATION
ORGANISING SECRETARIAT
European School of Oncology
Rare Tumours Programme
c/o Fondazione IRCCS Istituto Nazionale dei Tumori
Via G. Venezian, 1
20133 Milano - Italy
Fax +39 0223902531 - www.eso.net
Email: [email protected]
VENUE
Swiss Chamber - Sala Meili
Via Palestro, 2
20121 Milano - Italy
Tel. +39 027632031
www.swisschamber.it
REGISTRATION
REGISTER ONLINE AT WWW.ESO.NET
Early
Late
(by 30 September 2016)
(from 1 October 2016)
Registration fee
EUR 200
Club ESO Members
EUR 150
ESMO Members
EUR 150
EUR 250
Rates are quoted in Euro and include VAT.
Registration grants participation in all sessions, coffee breaks and lunches as
indicated in the programme.
TRAVEL GRANTS
Travel grants (registration, 2-night accommodation and travel expenses
contribution, up to the total amount of the grant) are made available on a
competitive basis thanks to the support of Rare Cancers Europe.
Priority will be given to younger candidates and low/middle income Countries.
Participants coming from:
•
•
•
•
Italy
Southern and Western Europe
Northern, Central and Eastern Europe
Other and overseas
EUR 650
EUR 850
EUR 950
EUR 1150
Applications should be submitted by 30 September 2016 to:
[email protected]
and include:
• Short curriculum vitae with full affiliation, contact details and date of birth;
• Letter describing motivation for attending.
Flyer Rare Tumours (30 Aug)_screen 30.08.2016 13:19 Pagina 8
ACCREDITATION
Application for CME recognition will be submitted to Accreditation Council of
Oncology in Europe (ACOE), to the European Accreditation Council for
Continuing Medical Education (EACCME) and to the Italian CME accreditation
system. EACCME credits are recognised by the American Medical Association
towards the Physician’s Recognition Award (PRA).
Information on the status of the applications can be obtained from the
organising Secretariat.
CANCELLATION OF REGISTRATION OR REPLACEMENT
Cancellation should be notified to ESO in writing. In case of cancellation without
replacement, the fee, less handling charges of EUR 80, will be refunded after the
event, provided that the cancellation is received by ESO before 25 October.
Replacements will be possible till 25 October.
BADGE
The badge is the only official evidence of registration and should be worn at all
times during the event.
INSURANCE
The organisers bear no responsibility for untoward events in relation to the
participation in the Course. Participants are advised to take out their own
personal and travel insurance.
OFFICIAL LANGUAGE
The official language will be English. No translation will be provided.
IMPORTANT DEADLINES
Travel grants: 30 September 2016
Early registration: 30 September 2016
Late registration: from 1 October 2016
Flyer Rare Tumours (30 Aug)_screen 30.08.2016 13:19 Pagina 2
REGISTRATION FORM
CLINICAL UPDATE ON RARE ADULT SOLID CANCERS, 25-27 November 2016, Milan, Italy
Please fill in this form in BLOCK CAPITALS and send by the deadline to:
European School of Oncology - Via Turati 29 - 20121 Milan - Italy
Fax: +39 02 85464545 - E mail: [email protected]
ONLINE REGISTRATION AT WWW.ESO.NET
PARTICIPANT'S DETAILS
Dr.
Prof.
Mrs.
Mr.
Surname
Institute
Department
Street
Zip Code
Town
Phone
Fax
Email
Profession
Specialisation
VAT number (compulsory for self-employed persons)
Fiscal code (Italian residents only)
Name
Country
Mobile
Main field
If your invoice details are different to those above, please complete the following section:
Invoice contact person
Address
Phone
VAT number (compulsory for self-employed persons)
Fiscal Code (Italian residents only)
email
REGISTRATION FEES:
Rates are quoted in Euro and include VAT.
Registration fee
Club ESO Members
ESMO Members
Early
(by 30 September 2016)
EUR 200
EUR 150
EUR 150
Late
(from 1 October 2016)
EUR 250
EUR 250
EUR 250
PAYMENT DETAILS:
The registration is processed when payment accompanies the form (credit card details or copy of bank transfer)
Visa/Mastercard
Card Number
Expire date
/
/
Holder’s name:
/
/
CV2 code
and signature
BANK TRANSFER with no cost to the beneficiary (please provide a copy of the bank transfer):
Bank:
Banca Popolare di Milano, Agenzia 24 - Milan, Italy
Account holder:
European School of Oncology
Number:
No. 16333
IBAN:
IT96G0558401624 0000000 16333 - BIC: BPMIITMMXXX
Reference:
"Rare Tumours" + participant’s name
I authorize the European School of Oncology to use my personal data according to what is specified in Article 13
DLGS 196, available at www.eso.net or on request at fax number +39 02 8546 4545.
Signature
Date
Download